Search Within

Jinjuan Yao

Formats
  1. Journal Article (31)
  2. Meeting Abstract (24)
  3. Review (3)
  4. Research Letter (2)
Groups
  1. Department of Pathology and Laboratory Medicine (60)
  2. Department of Medicine (33)
  3. Center for Hematologic Malignancies (29)
  4. Hematologic Malignancies, Division of (29)
  5. GSK Faculty (23)
  6. Human Oncology and Pathogenesis Program (21)

More Groups

People
  1. Maria Arcila (39)
  2. Khedoudja Nafa (23)
  3. Ahmet Dogan (21)
  4. Mikhail Roshal (18)
  5. Caleb Ho (16)
  6. Kseniya Petrova-Drus (16)

More People

Years
  1. 2025 (1)
  2. 2024 (5)
  3. 2023 (8)
  4. 2022 (4)
  5. 2021 (8)
  6. 2020 (2)

More Years

Publications
  1. Journal of Molecular Diagnostics (16)
  2. Blood (10)
  3. Archives of Pathology & Laboratory Medicine (5)
  4. Laboratory Investigation (4)
  5. Cancer Research (3)
  6. Cold Spring Harbor Molecular Case Studies (2)

More Publications

Publishers
  1. Elsevier Science, Inc. (16)
  2. American Society of Hematology (10)
  3. Nature Publishing Group (7)
  4. College of American Pathologists (5)
  5. American Association for Cancer Research (3)
  6. Cold Spring Harbor Laboratory Press (2)

More Publishers

Results (60)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Depletion of core needle biopsy cellularity and DNA content as a result of vigorous touch preparations
    Journal Article

    Rekhtman, N.; Kazi, S.; Yao, J.; Dogan, S.; Yannes, A.; Lin, O.; Silk, M.; Silk, T.; Durack, J. C.
    Archives of Pathology & Laboratory Medicine (2015)

    Fulltext@MSK | Save
  • Memorial Sloan Kettering-Integrated Mutation Profiling of Actionable Cancer Targets (MSK-IMPACT): A hybridization capture-based next-generation sequencing clinical assay for solid tumor molecular oncology
    Journal Article

    Cheng, D. T.; Mitchell, T. N.; Zehir, A.; Shah, R. H.; Benayed, R.; Syed, A.; Chandramohan, R.; Liu, Z. Y.; Won, H. H.; Scott, S. N.; more...
    Journal of Molecular Diagnostics (2015)

    Fulltext@MSK | Save
  • Synchronous lung adenocarcinoma and primary pulmonary MALT lymphoma: An underdiagnosed entity associated with KRAS mutations
    Meeting Abstract

    Yao, J.; Rehktman, N.; Nafa, K.; Dogan, A.; Ladanyi, M.; Arcila, M. E.
    Laboratory Investigation (2014)

    Fulltext@MSK | Save
  • Losing your touch? Depletion of core needle biopsies by touch preparations: Ex-vivo modeling of an adverse consequence of on-site assessment
    Meeting Abstract

    Kazi, S.; Yao, J.; Dogan, S.; Sigel, C. S.; Andrade, P.; Lin, O.; Silk, M.; Silk, T.; Durack, J. C.; Solomon, S. B.; more...
    Laboratory Investigation (2014)

    Fulltext@MSK | Save
  • Genetic analysis of transforming events that convert chronic myeloproliferative neoplasms to leukemias
    Journal Article

    Abdel-Wahab, O.; Manshouri, T.; Patel, J.; Harris, K.; Yao, J.; Hedvat, C.; Heguy, A.; Bueso-Ramos, C.; Kantarjian, H.; Levine, R. L.; more...
    Cancer Research (2010)

    Fulltext@MSK | Save
  • TET2 and ASXL1 mutations in leukemic transformation of chronic myeloproliferative neoplasms
    Meeting Abstract

    Abdel-Wahab, O.; Manshouri, T.; Patel, J.; Harris, K.; Yao, J. J.; Hedvat, C. V.; Heguy, A.; Bueso-Ramos, C.; Kantarjian, H. M.; Levine, R. L.; more...
    Blood (2009)

    Fulltext@MSK | Save
  • Genetic characterization of TET1, TET2, and TET3 alterations in myeloid malignancies
    Journal Article

    Abdel-Wahab, O.; Mullally, A.; Hedvat, C.; Garcia-Manero, G.; Patel, J.; Wadleigh, M.; Malinge, S.; Yao, J.; Kilpivaara, O.; Bhat, R.; more...
    Blood (2009)

    Fulltext@MSK | Save
  • The ETS protein MEF is regulated by phosphorylation-dependent proteolysis via the protein-ubiquitin ligase SCFSkp2
    Journal Article

    Liu, Y.; Hedvat, C. V.; Mao, S.; Zhu, X. H.; Yao, J.; Nguyen, H.; Koff, A.; Nimer, S. D.
    Molecular and Cellular Biology (2006)

    Fulltext@MSK | Save
  • MEF regulates the growth of ovarian cancer cells
    Meeting Abstract

    Yao, J.; Hedvat, C. V.; Nimer, S. D.
    Cancer Research (2004)

    Fulltext@MSK | Save
  • Myeloid ELF1-like factor is a potent activator of interleukin-8 expression in hematopoietic cells
    Journal Article

    Hedvat, C. V.; Yao, J.; Sokolic, R. A.; Nimer, S. D.
    Journal of Biological Chemistry (2004)

    Fulltext@MSK | Save